Esperion Therapeutics

• Founded

  21 Jan 2008

Sources: search.gleif.org

• Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women

  Phase 4, Completed, 16 people, 1 Sept 2023

• NCT05694260

  Phase 2, Completed, 31 people, 23 Jan 2023

• NCT05263778

  Collaborator, Phase 4, Status unknown, 500 people, 3 Mar 2022

• NCT03531905

  Phase 2, Completed, 242 people, 22 May 2018

• NCT03337308

  Phase 3, Completed, 382 people, 8 Nov 2017

• NCT03193047

  Phase 2, Completed, 59 people, 20 Jun 2017

• NCT03067441

  Phase 3, Completed, 1,462 people, 1 Mar 2017

• NCT03051100

  Phase 2, Completed, 63 people, 13 Feb 2017

• NCT03001076

  Phase 3, Completed, 269 people, 22 Dec 2016

• Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo

  Phase 3, Completed, 13,970 people, 15 Dec 2016

• NCT02991118

  Phase 3, Completed, 779 people, 13 Dec 2016

• NCT02988115

  Phase 3, Completed, 345 people, 9 Dec 2016

• NCT02666664

  Phase 3, Completed, 2,230 people, 28 Jan 2016

• NCT02659397

  Phase 2, Completed, 68 people, 20 Jan 2016

• NCT01941836

  Phase 2, Completed, 349 people, 13 Sept 2013

• NCT01779453

  Phase 2, Completed, 58 people, 30 Jan 2013

Sources: clinicaltrials.gov

• Comprehensive benchmarking of somatic mutation detection by the SMaHT Network

  Fees or honoraria, 15 Oct 2026

• Association of Life's Essential 8 With Clonal Hematopoiesis and Coronary Artery Disease

  Fees or honoraria, 15 Oct 2026

• Derivation of a blood count-based machine learning model to prioritise sequencing for high-risk clonal haematopoiesis: a retrospective cohort study

  Fees or honoraria, 22 Sept 2026

• Genetic evidence supports the combined targeting of lipoprotein(a) and LDL cholesterol to reduce coronary artery disease risk

  Fees or honoraria, 3 Sept 2026

• Lipoprotein (a) variability in high cardiovascular risk individuals with hypertriglyceridemia and controlled LDL-C on statin therapy in REDUCE-IT

  Consulting or advice, Grants or research support, 2 Sept 2026

• Prognostication and clinical opportunities with AI for coronary artery calcium: a scoping review

  Consulting or advice, Fees or honoraria, Grants or research support, 27 Aug 2026

• Rates of Lipoprotein(a) Oxidation Accelerate at Elevated Levels and Attenuate With Atorvastatin Active Metabolites Compared With Other Statins

  Grants or research support, 24 Aug 2026

• Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis

  Consulting or advice, Fees or honoraria, 18 Aug 2026

• Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial

  Employment, Consulting or advice, Fees or honoraria, 18 Aug 2026

• Primary results of the VICTORION-NOVEL (LDL-C management Program in atherosclerotic cardiovascular disease patients with elevated LDL-C) lipid optimization multicenter implementation trial

  Consulting or advice, Grants or research support, Board or leadership role, 16 Jul 2026

• Evaluating algorithmic fairness in the performance of the AHA PREVENT equations versus pooled cohort equations among single-race and multiracial populations

  Consulting or advice, Fees or honoraria, 6 Jul 2026

• Multidomain risk profiles and documented polyvascular involvement across atherosclerotic vascular beds

  Consulting or advice, 19 Jun 2026

• Genomic, phenomic and geographic associations of leukocyte telomere length in the United States

  Fees or honoraria, 27 Mar 2026

• Detecting Transthyretin Cardiac Amyloidosis With Artificial Intelligence: A Nonrandomized Clinical Trial

  Consulting or advice, Fees or honoraria, 1 Feb 2026

• The continuum of prevention and heart failure in cardiovascular medicine: A joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology

  Fees or honoraria, 13 Aug 2025

• Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond

  Grants or research support, 25 Jun 2024

• Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss

  Consulting or advice, Board or leadership role, 4 Jun 2024

• Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease

  Consulting or advice, 23 May 2023

Sources: pubmed.ncbi.nlm.nih.gov

• Diabetes Staging System (DSS)—A Novel Approach to Improve SGLT2i/GLP-1RA Use and CVD/CKD Outcomes in DM2

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025